Advanced biomaterials and digital twins for precision psychiatry: neuroimmune modulation and AI-guided therapeutics
Wentao Wu, Xin Xu, Jiaxin Hu, Jiali He, Mingzhe Yang, Fei Wen · 2026
Read Advanced biomaterials and digital twins for precision psychiatry: neuroimmune modulation and AI-guided therapeutics by Wentao Wu, Xin Xu, Jiaxin Hu, Jiali He, Mingzhe Yang, Fei Wen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13553854.txt.
Description
Wentao Wu and five colleagues argue that precision psychiatry should be rebuilt as bioengineering, not just better algorithms, in a 2026 perspective. Diagnosis today sorts patients by symptoms, yet people with the same label diverge wildly in course and drug response. The biology underneath braids brain circuits with immune, hormone, gut, and sleep systems.
Their proposal has two working parts. Advanced biomaterials should act as programmable interfaces that actively modulate the brain's immune and chemical environment, not merely ferry drugs. Digital twins, patient-specific models fed by many data streams, should steer choices: which material, which stimulation settings, which drug, judged over time. Three priorities follow: model dynamic disease states, treat materials as therapies, and grade digital tools by whether they guide safe action. The authors aim the framework at six major disorders, from depression to addiction.
Catalog record
| CREATOR | Wentao Wu, Xin Xu, Jiaxin Hu, Jiali He, Mingzhe Yang, Fei Wen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |